Up a level |
Smith, Philip, Critchley, Lisa, Storey, Daniel ORCID: 0000-0001-8101-8429, Gregg, Belle, Stenson, June, Kneebone, Andrew, Rimmer, Tracy, Burke, Stevena, Hussain, Shamas, Teoh, Wan Yi et al (show 10 more authors)
(2022)
EFFICACY AND SAFETY OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS IFX (CT-P13): A MULTI-CENTRE COHORT STUDY.
In: Abstracts of the BSG Annual Meeting, 20–23 June 2022.
Smith, Philip J, Critchley, Lisa, Storey, Daniel, Gregg, Belle, Stenson, June, Kneebone, Andrew, Rimmer, Tracy, Burke, Stevena, Hussain, Shamas, Yi Teoh, Wan et al (show 10 more authors)
(2022)
Efficacy and Safety of Elective Switching from Intravenous to Subcutaneous Infliximab [CT-P13]: A Multicentre Cohort Study.
JOURNAL OF CROHNS & COLITIS, 16 (9).
pp. 1436-1446.
Lenti, Marco Vincenzo, Levison, Scott, Eliadou, Elena, Willert, Robert, Kemp, Karen, Carter, Anna, Stansfield, Catherine, Assadsangabi, Arash, Singh, Salil, Crooks, Ben et al (show 13 more authors)
(2018)
A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine study.
DIGESTIVE AND LIVER DISEASE, 50 (12).
pp. 1299-1304.